Medicamentos Refrigerados
Mantener valores actualizados para el año 2012, para dar cumplimiento a las programaciones de compras mensuales informadas por Farmacia.
26 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 2130-2023-SE13 | 25-02-2013 | Laboratorio Sanderson S.A. | $102.816 |
| 2130-2020-SE13 | 25-02-2013 | Grifols Chile S.A. | $8.520.400 |
| 2130-2024-SE13 | 25-02-2013 | Novo Nordisk Farmaceutica Limitada | $2.677.500 |
| 2130-2025-SE13 | 25-02-2013 | Productos Farmoquimicos Roche Limitada | $1.585.080 |
| 2130-2026-SE13 | 25-02-2013 | Aventis Pharma Holding Gmbh | $2.556.418 |
| 2130-1071-SE13 | 29-01-2013 | Grifols Chile S.A. | $2.541.840 |
| 2130-802-SE13 | 24-01-2013 | Grifols Chile S.A. | $6.354.600 |
| 2130-803-SE13 | 24-01-2013 | Laboratorio Sanderson S.A. | $102.816 |
| 2130-805-SE13 | 24-01-2013 | Productos Farmoquimicos Roche Limitada | $3.170.160 |
| 2130-806-SE13 | 24-01-2013 | Aventis Pharma Holding Gmbh | $2.069.529 |
| 2130-807-SE13 | 24-01-2013 | Novo Nordisk Farmaceutica Limitada | $3.760.400 |
| 2130-655-SE13 | 16-01-2013 | Laboratorios Recalcine S.A. | $1.041.250 |
| 2130-527-SE13 | 14-01-2013 | Grifols Chile S.A. | $16.945.600 |
| 2130-417-SE13 | 14-01-2013 | Laboratorios Recalcine S.A. | $1.041.250 |
| 2130-149-SE13 | 08-01-2013 | Laboratorios Recalcine S.A. | $833.000 |
| 2130-106-SE13 | 04-01-2013 | Novo Nordisk Farmaceutica Limitada | $1.618.400 |
| 2130-105-SE13 | 04-01-2013 | Laboratorio Sanderson S.A. | $102.816 |
| 2130-107-SE13 | 04-01-2013 | Aventis Pharma Holding Gmbh | $3.530.195 |
| 2130-104-SE13 | 04-01-2013 | Grifols Chile S.A. | $12.852.000 |
| 2130-11764-SE12 | 31-12-2012 | Laboratorios Recalcine S.A. | $1.249.500 |
| 2130-11401-SE12 | 20-12-2012 | Grifols Chile S.A. | $6.426.000 |
| 2130-10206-SE12 | 21-11-2012 | Productos Farmoquimicos Roche Limitada | $4.226.880 |
| 2130-10205-SE12 | 21-11-2012 | Novo Nordisk Farmaceutica Limitada | $7.009.100 |
| 2130-10210-SE12 | 21-11-2012 | Grifols Chile S.A. | $8.472.800 |
| 2130-10209-SE12 | 21-11-2012 | Aventis Pharma Holding Gmbh | $3.530.195 |
| 2130-10207-SE12 | 21-11-2012 | Laboratorio Sanderson S.A. | $517.412 |
| 2130-9330-SE12 | 25-10-2012 | Libra Chile S.A. | $1.499.400 |
| 2130-3387-SE12 | 25-10-2012 | Laboratorios Raffo S.A. | $364.140 |
| 2130-9331-SE12 | 25-10-2012 | Novo Nordisk Farmaceutica Limitada | $5.545.400 |
| 2130-9332-SE12 | 25-10-2012 | Productos Farmoquimicos Roche Limitada | $2.641.800 |
| 2130-9325-SE12 | 24-10-2012 | Aventis Pharma Holding Gmbh | $2.069.529 |
| 2130-9324-SE12 | 24-10-2012 | Grifols Chile S.A. | $18.171.300 |
| 2130-9011-SE12 | 11-10-2012 | Productos Farmoquimicos Roche Limitada | $264.180 |
| 2130-8822-SE12 | 05-10-2012 | Grifols Chile S.A. | $12.709.200 |
| 2130-8824-SE12 | 05-10-2012 | Laboratorio Sanderson S.A. | $274.176 |
| 2130-8814-SE12 | 05-10-2012 | Aventis Pharma Holding Gmbh | $3.417.957 |
| 2130-8816-SE12 | 05-10-2012 | Grifols Chile S.A. | $9.746.100 |
| 2130-8818-SE12 | 05-10-2012 | Productos Farmoquimicos Roche Limitada | $3.170.160 |
| 2130-8810-SE12 | 05-10-2012 | Alpes Selection Productos Farmaceuticos Ltda. | $321.300 |
| 2130-8812-SE12 | 05-10-2012 | Libra Chile S.A. | $999.600 |
| 2130-8531-SE12 | 27-09-2012 | Grifols Chile S.A. | $7.625.520 |
| 2130-8339-SE12 | 25-09-2012 | Grifols Chile S.A. | $4.236.400 |
| 2130-8348-SE12 | 25-09-2012 | Novo Nordisk Farmaceutica Limitada | $6.104.700 |
| 2130-8136-SE12 | 21-09-2012 | Grifols Chile S.A. | $4.236.400 |
| 2130-7740-SE12 | 05-09-2012 | Grifols Chile S.A. | $2.541.840 |
| 2130-3386-SE12 | 24-08-2012 | Alpes Selection Productos Farmaceuticos Ltda. | $214.200 |
| 2130-7347-SE12 | 24-08-2012 | Laboratorio Sanderson S.A. | $171.360 |
| 2130-7350-SE12 | 24-08-2012 | Novo Nordisk Farmaceutica Limitada | $2.368.100 |
| 2130-7351-SE12 | 24-08-2012 | Productos Farmoquimicos Roche Limitada | $2.641.800 |
| 2130-7353-SE12 | 24-08-2012 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 2130-7346-SE12 | 24-08-2012 | Grifols Chile S.A. | $4.676.700 |
| 2130-6498-SE12 | 01-08-2012 | Novo Nordisk Farmaceutica Limitada | $6.455.750 |
| 2130-6499-SE12 | 01-08-2012 | Laboratorio Sanderson S.A. | $42.840 |
| 2130-6497-SE12 | 01-08-2012 | Aventis Pharma Holding Gmbh | $3.700.656 |
| 2130-5787-SE12 | 12-07-2012 | Grifols Chile S.A. | $1.059.100 |
| 2130-5570-SE12 | 09-07-2012 | Novo Nordisk Farmaceutica Limitada | $4.355.400 |
| 2130-5540-SE12 | 09-07-2012 | Grifols Chile S.A. | $13.934.900 |
| 2130-5571-SE12 | 09-07-2012 | Laboratorio Sanderson S.A. | $145.656 |
| 2130-5573-SE12 | 09-07-2012 | Libra Chile S.A. | $499.800 |
| 2130-5575-SE12 | 09-07-2012 | Productos Farmoquimicos Roche Limitada | $1.320.900 |
| 2130-5579-SE12 | 09-07-2012 | Aventis Pharma Holding Gmbh | $3.554.590 |
| 2130-5588-SE12 | 09-07-2012 | Grifols Chile S.A. | $8.472.800 |
| 2130-3389-SE12 | 01-06-2012 | Productos Farmoquimicos Roche Limitada | $2.641.800 |
| 2130-3382-SE12 | 16-05-2012 | Laboratorios Recalcine S.A. | $4.165.000 |
| 2130-3831-SE12 | 10-05-2012 | Novo Nordisk Farmaceutica Limitada | $238.000 |
| 2130-3384-SE12 | 03-05-2012 | Laboratorio Sanderson S.A. | $51.408 |
| 2130-3383-SE12 | 03-05-2012 | Grifols Chile S.A. | $6.426.000 |
| 2130-3379-SE12 | 03-05-2012 | Novo Nordisk Farmaceutica Limitada | $4.498.200 |
| 2130-3380-SE12 | 03-05-2012 | Libra Chile S.A. | $1.249.500 |
| 2130-3381-SE12 | 26-04-2012 | Aventis Pharma Holding Gmbh | $2.580.813 |
Fuente original:ficha mercadopublico.cl
